ELI LILLY & Co — Director's Dealing 2012

Feb 2, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2012-02-01

Reporting Person: Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-01	Common Stock	M	87924	$0.00	Acquired	139110	Direct
2012-02-01	Common Stock	F	36463	$39.74	Disposed	102647	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-01	Restricted Stock Unit	$0.00	M	87924	Disposed	2012-02-01	Common Stock (87924)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6869	Indirect